PEJMF 財務： Peijia Medical Limited AI 分析

首頁

股票

PEJMF

財務狀況

PEJMF 財務

Peijia Medical Limited

$1.38

收盤價：Mar 27, 16:00:00 GMT-4

$1.38

盤後：Mar 27, 20:00:00 GMT-4

概觀預測收益股利財務狀況

收入

資產負債表

現金流量

年度

每季

PEJMF 收入

財務數據以百萬美元計。會計年度為二月至一月。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
營收	667	615	441	250	136	38
營收年增率 (YoY)	28.99%	39%	76%	84%	258%	111%
營收成本	205	181	115	74	40	13
毛利	462	433	325	176	95	25
銷售、一般及管理費用	473	456	453	354	196	126
研發	218	192	284	366	440	98
營業費用	670	663	741	725	646	233
其他非營業收入 (費用)	--	--	0	--	--	--
稅前淨利	-222	-221	-391	-398	-574	-2,068
所得稅費用	6	6	1	9	0	0
淨利	-225	-226	-392	-407	-574	-2,068
淨利成長	-10%	-42%	-4%	-28.99%	-72%	289%
稀釋後流通股數	665.99	669.48	679.27	673.16	661.65	466.99
股數年變動 (YoY)	-2%	-1%	1%	2%	42%	2%
每股盈餘 (稀釋)	-0.34	-0.33	-0.57	-0.6	-0.86	-4.42
每股盈餘成長率	-8%	-41%	-5%	-30%	-80%	281%
自由現金流	-368	-285	-899	-578	-637	-209
每股自由現金流	--	--	--	--	--	--
毛利率	69.26%	70.4%	73.69%	70.39%	69.85%	65.78%
營業利益率	-31.18%	-37.23%	-94.33%	-219.2%	-405.14%	-544.73%
淨利率	-33.73%	-36.74%	-88.88%	-162.79%	-422.05%	-5,442.1%
自由現金流利潤率	-55.17%	-46.34%	-203.85%	-231.2%	-468.38%	-550%
EBITDA	-174	-195	-394	-532	-535	-191
EBITDA 利潤率	-26.08%	-31.7%	-89.34%	-212.8%	-393.38%	-502.63%
EBITDA 中的折舊與攤銷	34	34	22	16	16	16
EBIT	-208	-229	-416	-548	-551	-207
EBIT 利潤率	-31.18%	-37.23%	-94.33%	-219.2%	-405.14%	-544.73%
有效稅率	-2.7%	-2.71%	-0.25%	-2.26%	0%	0%

Follow-Up Questions

Peijia Medical Limited 的關鍵財務報表是什麼？



根據最新的財務報表（Form-10K），Peijia Medical Limited 的總資產為 $0，淨isProfitable}為 $-226

PEJMF 的關鍵財務比率是什麼？



Peijia Medical Limited 的流動比率為 0，淨利潤率為 -36.74，每股銷售為 $0.91。

Peijia Medical Limited 的收入按細分市場或地理位置如何劃分？



Peijia Medical Limited 最大收入來源為 Neurointerventional，在最近的收益報告中收入為 385,492,551。就地區而言，China 是 Peijia Medical Limited 的主要市場，收入為 667,321,372。

Peijia Medical Limited 是否盈利？



無，根據最新的財務報表，Peijia Medical Limited 的淨損失為 $-226

Peijia Medical Limited 有負債嗎？



無，Peijia Medical Limited 的負債為 0

Peijia Medical Limited 的流通股有多少？



Peijia Medical Limited 的總流通股為 0

關鍵數據

前收市價

$1.38

開盤價

$1.38

當日範圍

$1.38 - $3.5

52週區間

$1.38 - $3.5

交易量

76.0K

平均成交量

股息收益率

每股盈餘 (TTM)

-0.11

市值

$924.5M

什麼是 PEIJIA MEDICAL LIMITED？

Peijia Medical Ltd. engages in the manufacture and sale of medical devices. The company is headquartered in Suzhou, Jiangsu and currently employs 1,035 full-time employees. The company went IPO on 2020-05-15. The firm primarily operates its businesses through two segments, Transcatheter Valve Therapeutic Business segment and Neurointerventional Business segment. Transcatheter Valve Therapeutic Business segment is mainly engaged in the business of research and development, manufacturing and sales of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is mainly involved in the business of research and development, manufacturing and sales of neurointerventional procedural medical devices. The Company’s products include commercialized products such as TaurusOne and TaurusElite. The firm mainly conducts its businesses in the domestic market.

功能特性

資源